From 30 September 2024, the following insulins will no longer be available in Aotearoa New Zealand: Penmix30, Penmix50 and Mixtard30.
NZSSD has issued recommendations for switching to alternative insulins (file linked below), but please be aware Novomix30 is dispensed in a pre-filled disposable pen, whereas patients will require a Humapen for the Humulin and Humalog configurations as these insulins are dispensed in cartridges.
This may be the ideal time to review the management of your patients prescribed Penmix30, Penmix50, or Mixtard30, as they may be suitable for non-insulin medication that was not available when they first started using insulin.
Consider referring these patients to the diabetes lead nurse in your practice, or contacting the Pinnacle clinical diabetes specialist in your area if you would like further information about this.
Sue van Mierlo is a nurse practitioner working as part of the Lakes Extended Care Team. In her role she supports people to self-manage long-term conditions and diseases, including managing diabetes. A large number of her clients are Māori.
Read moreTechnology for all people living with type 1 (T1) diabetes has been fully funded since October 2024, with 66 per cent of people with T1 in Waikato now using Automated Insulin Delivery (AID). If you have patients with T1 not using an insulin pump, please discuss the benefits of AID and refer them to the Regional Diabetes Service via BPAC for assessment and support.
Read moreThe clinical diabetes specialist in primary care provides clinical mentorship and advice to the practice team in supporting patients with diabetes.
View detailsA guide for clinical management of type 2 diabetes, to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.